At JDRF we’re leading the fight against type 1 diabetes by funding research to improve lives and cure the disease.
We drive innovation, demand action and stand with everyone facing life with type 1 diabetes (T1D).
Research is the key to destroy T1D
Australians have type 1 diabetes.
Has been invested in Australian research to-date.
Bi-partisan promise in 2019.
What is type 1 diabetes?
Type 1 diabetes (T1D) is a lifelong autoimmune disease that destroys the body’s ability to process sugar by attacking the beta cells in the pancreas that produce insulin. Insulin helps convert sugar into the fuel that our bodies need. Without insulin, sugar builds up in the bloodstream in life-threatening amounts. Since people with T1D cannot produce insulin naturally, they must take it either through multiple daily injections or from an insulin pump.More about T1D
Improving lives each day until a cure.
While we search for a cure we are working to improve the lives of millions of Australians impacted by T1D. We fast-track new treatments and technology, and advocate for financial support for those who need it most.
We’ve been part of every breakthrough in T1D care in the last 45 years.Our Research
What we've achieved so far...
In Government subsidies.
Fewer needles with our Insulin Pump Program.
Funding for the T1DCRN
Find out more about us!
About JDRF Australia?
JDRF is the leading supporter of type 1 diabetes research in the world. Our vision? A world without type 1 diabetes.
As the leading supporter of type 1 diabetes research globally, we’ve been part of every major breakthrough in T1D care in the past 45 years.
How you can get involved
Donate, volunteer, fundraise or advocate! However you choose to get involved, your contribution could help us create a world without T1D.
JDRF's Latest News
#AccessForAll – JDRF launches new campaign to increase access to life saving and life changing technology
Life-saving and life-changing technologies to measure blood glucose and deliver insulin in response to need are the foundation of type 1 diabetes (T1D) treatment and care in the 21st century. But in Australia, access to these technologies is inconsistent, inequitable, and incomplete. Even worse, they cut out for many on adulthood. This needs to change. […]
MP Profile: A JDRF exclusive with Ross Vasta MP
JDRF’s politician profiles are an opportunity to talk to people across the political spectrum and get an insight into their thoughts about type 1 diabetes, what their JDRF Advocate meetings mean to them and more. This month, we got in touch with Ross Vasta MP – Federal Member for Bonner and learned about the first […]
Talking T1D advocacy with 10-year old Dougal McGregor
Every month, we’ll be putting a spotlight one of our incredible advocates who give voice to the lived experience of type 1 diabetes (T1D) and help politicians better understand the needs of the T1D community. Recently, we had a little chat with Dougal McGregor. Dougal is a 10-year old JDRF advocate from Shepparton, Victoria who has been […]
JDRF welcomes senior business leader Ian Narev to the JDRF Board
Mr Narev will bring more than 30 years of strategy and leadership experience garnered across consulting finance and technology businesses. JDRF Australia are delighted to welcome Ian Narev, Managing Director and Chief Executive Officer of SEEK to the Board. Mr Narev, who joined the Board at the September 2021 Board meeting, is no stranger to JDRF having spent several years as co-Chair of the JDRF Australia Advisory Board. Alongside his historical […]
Meet the inspiring father-daughter duo taking on the JDRF One Ride Challenge!
Let’s meet the inspiring father-daughter duo who share a passion for BMX riding and a goal to help defeat type 1 diabetes. Daniel was diagnosed with type 1 diabetes (T1D) at a young age, but that didn’t stop him from becoming a proud father of two, a motorcycle racer, and a mentor and supporter to […]
JDRF launches pilot study of general population screening for type 1 diabetes
Last year, JDRF appointed Dr Kirstine Bell from the Charles Perkins Centre, University of Sydney, to lead a pilot study to screen for risk of type 1 diabetes in the general population. Today, Dr Bell launched the national screening project and revealed new details about what it will involve. “Children are often diagnosed with type […]
COVID-19 Vaccines and T1D: Answering Your Questions
UPDATED 2 August 2021 Australia has begun the rollout of two COVID-19 vaccines — one from Pfizer, and one from AstraZeneca. Both these vaccines are safe and effective at protecting people against COVID-19, and all Australians are encouraged to get vaccinated. With vaccines now being offered to people with T1D, we’ve gathered all the information […]
JDRF welcomes TGA approval on Pfizer vaccine for children aged 12-15
JDRF Australia welcomes the announcement that the Therapeutic Goods Administration (TGA) has approved the Pfizer COVID-19 vaccine for children aged 12-15. We look forward to the final decision from the Australian Technical Advisory Group on Immunisation (ATAGI) to prioritise children with underlying conditions, including type 1 diabetes, and include them immediately in the vaccine rollout. […]
JDRF welcomes leading medical researcher to Board to support continued research excellence
JDRF Australia are delighted to welcome Professor Fabienne Mackay to the Board of JDRF Australia. Professor Mackay, who joined the Board at the June 2021 Board meeting, will also play an important role on JDRF’s Board Research Committee, evaluating and ensuring JDRF continues to support the best local research into type 1 diabetes (T1D). Prof. Mackay obtained her PhD from Louis Pasteur University in Strasbourg, France and has more than […]
I am interested in hearing more about…